论文信息 - Real world incidence and management of adverse events in patients with HR+, HER2− metastatic breast cancer receiving CDK4 and 6 inhibitors in a United States community setting - 字舞流文

Real world incidence and management of adverse events in patients with HR+, HER2− metastatic breast cancer receiving CDK4 and 6 inhibitors in a United States community setting

P. Ryan | W. Gathirua-Mwangi | K. Sheffield | Yu-jing Huang | G. Cuyun Carter | S. Rybowski | L. Sudharshan | Claudia Morato Guimaraes | G. Price | Jonathan Rajkumar | E. N. Nash Smyth | E. Nash Smyth | Emily Nash Smyth